Tuesday, October 27, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Semaglutide in Patients with Obesity and Psoriasis: Insights from an 18-Month Real-World Experience

Journal of clinical medicine · 2026 Oct 16 · Proietti I, Potenza C et

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 15 20:00 ETSource: Journal of clinical medicine

From the source

Semaglutide in Patients with Obesity and Psoriasis: Insights from an 18-Month Real-World Experience

Journal of clinical medicine · 2026 Oct 16 · Proietti I, Potenza C et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →